Literature DB >> 10201907

Absence of Peyer's patches and abnormal lymphoid architecture in chronic proliferative dermatitis (cpdm/cpdm) mice.

H HogenEsch1, S Janke, D Boggess, J P Sundberg.   

Abstract

The chronic proliferative dermatitis (cpdm) mutation causes inflammation in multiple organs, most prominently in the skin. Examination of the immune system revealed severe abnormalities in the architecture of lymphoid tissues. Peyer's patches were absent. In contrast, the spleen, lymph nodes, and nasal-associated lymphoid tissues were present. The spleen had normal numbers of T and B cells, but the spleen, lymph nodes, and nasal-associated lymphoid tissues had poorly defined follicles and lacked germinal centers and follicular dendritic cells. The marginal zone in the spleen was absent. The total concentration of serum IgG, IgA, and IgE in cpdm/cpdm mice was significantly decreased, whereas serum IgM was normal. Fecal IgA was low to undetectable in mutant mice, and the concentration of fecal IgM was increased. The titer of DNP-specific Abs following immunization with DNP-keyhole limpet hemocyanin was significantly decreased for all IgG subclasses. In contrast, T cell function appeared normal as assessed by evaluation of the contact hypersensitivity response in cpdm/cpdm mice. The cpdm mutation causes a complex phenotype that is characterized by multiorgan inflammation and the defective development of lymphoid tissues. The cpdm/cpdm mouse may be a useful model to study the factors that control the development of lymphoid tissues, in particular the Peyer's patches, and the mechanisms that control the humoral immune response.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10201907

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  34 in total

Review 1.  Tumor necrosis factor-driven cell death in donor organ as a barrier to immunological tolerance.

Authors:  Rosalind L Ang; Adrian T Ting
Journal:  Curr Opin Organ Transplant       Date:  2019-02       Impact factor: 2.640

2.  SHARPIN regulates mitochondria-dependent apoptosis in keratinocytes.

Authors:  Yanhua Liang; John P Sundberg
Journal:  J Dermatol Sci       Date:  2011-05-07       Impact factor: 4.563

3.  Differential Involvement of the Npl4 Zinc Finger Domains of SHARPIN and HOIL-1L in Linear Ubiquitin Chain Assembly Complex-Mediated Cell Death Protection.

Authors:  Satoshi Shimizu; Hiroaki Fujita; Yoshiteru Sasaki; Tatsuaki Tsuruyama; Kazuhiko Fukuda; Kazuhiro Iwai
Journal:  Mol Cell Biol       Date:  2016-05-02       Impact factor: 4.272

4.  Loss of FAS/FASL signalling does not reduce apoptosis in Sharpin null mice.

Authors:  Christopher S Potter; Kathleen A Silva; Victoria E Kennedy; Timothy M Stearns; Harm HogenEsch; John P Sundberg
Journal:  Exp Dermatol       Date:  2017-05-03       Impact factor: 3.960

5.  Inhibition of NF-κB signaling retards eosinophilic dermatitis in SHARPIN-deficient mice.

Authors:  Yanhua Liang; Rosemarie E Seymour; John P Sundberg
Journal:  J Invest Dermatol       Date:  2010-09-02       Impact factor: 8.551

6.  SHARPIN is a component of the NF-κB-activating linear ubiquitin chain assembly complex.

Authors:  Fuminori Tokunaga; Tomoko Nakagawa; Masaki Nakahara; Yasushi Saeki; Masami Taniguchi; Shin-ichi Sakata; Keiji Tanaka; Hiroyasu Nakano; Kazuhiro Iwai
Journal:  Nature       Date:  2011-03-31       Impact factor: 49.962

7.  Linear ubiquitination prevents inflammation and regulates immune signalling.

Authors:  Björn Gerlach; Stefanie M Cordier; Anna C Schmukle; Christoph H Emmerich; Eva Rieser; Tobias L Haas; Andrew I Webb; James A Rickard; Holly Anderton; Wendy W-L Wong; Ueli Nachbur; Lahiru Gangoda; Uwe Warnken; Anthony W Purcell; John Silke; Henning Walczak
Journal:  Nature       Date:  2011-03-31       Impact factor: 49.962

8.  A new model for dermatitis herpetiformis that uses HLA-DQ8 transgenic NOD mice.

Authors:  Eric Marietta; Kay Black; Michael Camilleri; Patricia Krause; Roy S Rogers; Chella David; Mark R Pittelkow; Joseph A Murray
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

9.  Dietary fructooligosaccharides up-regulate immunoglobulin A response and polymeric immunoglobulin receptor expression in intestines of infant mice.

Authors:  Y Nakamura; S Nosaka; M Suzuki; S Nagafuchi; T Takahashi; T Yajima; N Takenouchi-Ohkubo; T Iwase; I Moro
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

10.  Defective immune responses in mice lacking LUBAC-mediated linear ubiquitination in B cells.

Authors:  Yoshiteru Sasaki; Soichi Sano; Masaki Nakahara; Shigeo Murata; Kohei Kometani; Yuichi Aiba; Shinji Sakamoto; Yoshihiro Watanabe; Keiji Tanaka; Tomohiro Kurosaki; Kazuhiro Iwai
Journal:  EMBO J       Date:  2013-08-13       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.